Raymond James & Associates »

Viking Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $20M 245k 82.00
2023-12-31 $2.6M 138k 18.61
2023-09-30 $760k 69k 11.07
2023-06-30 $1.1M 69k 16.21
2023-03-31 $765k 46k 16.65
2022-12-31 $882k 94k 9.40
2022-09-30 $285k 105k 2.72
2022-06-30 $327k 113k 2.89
2022-03-31 $371k 124k 3.00
2021-12-31 $631k 137k 4.60
2021-09-30 $1.6M 251k 6.28
2021-06-30 $1.6M 259k 5.99
2021-03-31 $2.5M 402k 6.33
2020-12-31 $1.7M 293k 5.63
2020-09-30 $2.2M 380k 5.82
2020-06-30 $2.7M 380k 7.21
2020-03-31 $1.2M 259k 4.68
2019-12-31 $2.1M 262k 8.02
2019-09-30 $2.4M 345k 6.88
2019-06-30 $2.9M 345k 8.30
2019-03-31 $3.3M 330k 9.94
2018-12-31 $1.3M 165k 7.65
2018-09-30 $2.5M 143k 17.42